Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction

Inflammation Research

Volumn 55, Issue 9, 2006, Pages 385-392

  Gao, J ^a   Zhao, W X ^a   Zhou, L J ^a   Zeng, B X ^b   Yao, S L ^b   Liu, D ^b   Chen, Z Q ^c  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c NONE

Author keywords

Lipopolysaccharide; Nitric oxide synthase; Nitrotyrosine; Nuclear factor kB; Propofol

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; F ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTRALIPID; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROPOFOL; SOLVENT;

ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UMBILICAL VEIN; WESTERN BLOTTING;

ACTINS; CELLS, CULTURED; ENDOTHELIAL CELLS; FREE RADICAL SCAVENGERS; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PERMEABILITY; PROPOFOL; RNA, MESSENGER; TYROSINE; UMBILICAL CORD;

EID: 35248847123     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-5116-0     Document Type: Article

References (35)

1. Bannerman DD, Goldblum SE. Direct effects of endotoxin on the endothelium: barrier function and injury. Lab Invest 1999; 79: 1181-99.
2. Cuschleri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Endotoxin-induced endothelial cell proinflammatory phenotypic differentiation requires stress fiber polymerization. Shock 2003; 19: 433-9.
3. Chakravortty D, Koide N, Kato Y, Sugiyama T, Kawai M, Fukada M et al. Cytoskeletal alterations in lipopolysaccharide-induced bovine vascular endothelial cell injury and its prevention by sodium arsenite. Clin Diagn Lab Immunol 2000; 7: 218-25.
4. Goldblum SE, Ding X, Brann TW, Campbell-Washington J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J Cell Physiol 1993; 157: 13-23.
5. Knepler JL Jr, Taher LN, Gupta MP, Patterson C, Pavalko F, Ober MD et al. Peroxynitrite causes endothelial cell monolayer barrier dysfunction. Am J Physiol Cell Physiol 2001; 281: C1064-75.
6. Sittipunt C, Steinberg KP, Ruzinski JT, Myles C, Zhu S, Goodman RB et al. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163: 503-10.
7. Gu Z, Ling Y, Cong B. Peroxynitrite mediated acute lung injury induced by lipopolysaccharides in rats. Zhonghua Yi Xue Za Zhi 2000; 80: 58-61.
8. Marik PE, Zaloga GP: Therapeutic sedation: has its time come? Crit Care Med 2002; 30: 949-52.
9. Young C, Knudsen N, Andrew H. Sedation in the intensive care unit. Crit Care Med 2000; 28: 854-66.
10. Kwak SH, Choi JI, Park JT. Effects of propofol on Endotoxin-induced Acute Lung Injury in Rabbit. J Korean Med Sci 2004; 19: 55-61.
11. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002; 30: 904-7.
12. Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC et al. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide- activated macrophages. Ann NY Acad Sci 2005; 1042: 262-71.
13. Mathy-Hartert M, Mouithys-Mickalad A, Kohnen S, Deby-Dupont G, Lamy M, Hans P. Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 2000; 55: 1066-71.
14. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. British J Anaesthesia 2004; 92: 277-9.
15. Magnuson DK, Weintraub A, Pohlman TH, Maier RV. Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide. J Immunol 1989; 143: 3025-30.
16. Schreiber E, Mathias P, Muller MM. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419-20.
17. Chang H, Tsai SY, Chang Y, Chen TL, Chen RM. Therapeutic concentrations of propofol protects mouse macrophages from nitric oxide-induced cell death and apoptosis. Can J Anaesth 2002; 49: 477-80.
18. Blaylock MG, Cuthbertson BH, Galley HF, Ferguson NR, Webster NR. The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes. Free Radic Biol Med 1998; 25: 748-52.
19. Royall, JA, Kooy NW, Beckman JS. Nitric oxide-related oxidants in acute lung injury. New Horiz 1995; 3: 113-22.
20. Li X, De Sarno P, Song L, Beckman JS, Jope RS. Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells. Biochem J 1998; 331: 599-606.
21. Ischiropoulosh, al-Mehdi AB. Peroxynitrite-mediated oxidative protein modification. FEBS Lett 1995; 364: 279-82.
22. Kaman S, Demiryurek AT. Propofol is a peroxynitrite scavenger. Anesth Analg 1997; 84: 1127-9.
23. Mathy-Hartert M, Mouithys-Mickalad A, Kohnen S, Deby-Dupont G, Lamy M, Hans P. Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 2000; 55: 1066-71.
24. Cardaropoli S, Silvagno F, Morra E, Pescarmona GP, Todros T. Infectious and inflammatory stimuli decrease endothelial nitric oxide synthase activity in vitro. J Hypertens 2003; 21: 2103-10.
25. Piepot HA, Boer C, Groeneveld AB, Van Lambalgen AA, Sipkema P. Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int 2000; 57: 2502-10.
26. Connelly L, Madhani M, Hobbs AJ. Resistance to Endotoxic Shock in Endothelial Nitric-oxide Synthase (eNOS) Knock-out Mice. J Biol Chem 2005; 280: 10040-6.
27. Hsu BG, Yang FL, Lee RP Peng TC, Chen HI. Effects of posttreatment with low-dose propofol on inflammatory responses to lipopolysaccharide-induced shock in conscious rats. Clin Exp Pharmacol Physiol 2005; 32: 24-9.
28. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005; 100: 810-6.
29. Takemoto Y. Dose effects of propofol on hemodynamic and cytokine responses to endotoxemia in rats. J Anesth 2005; 19: 40-4.
30. Tsao CM, Ho ST, Chen A, Wang JJ, Tsai SK, Wu CC. Propofol ameliorates liver dysfunction and inhibits aortic superoxide level in conscious rats with endotoxic shock. Eur J Pharmacol 2003; 477: 183-93.
31. Gao J, Zeng B, Zhou L, Yuan S, Zhang S. The therapeutic effects of early treatment with propofol on endotoxin-induced shock in rats. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 320-3.
32. Lush CW, Cepinskas G, Kvietys PR. Regulation of intestinal nuclear factor-kappaB activity and E-selectin expression during sepsis: a role for peroxynitrite. Gastroenterology 2003; 124: 118-28.
33. Christy-Lynn M. Cooke, Sandra T. Davidge. Peroxynitrite increase iNOS through NF-κB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 2002; 282: C395-402.
34. Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO III. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-κB in human coronary smooth muscle cells. Circ Res 2000; 87: 1006-11.
35. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-92.